Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|11|1245-1259

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.11, 2004-04, pp. : 1245-1259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1284-1290

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 109-118

Bentham Science Publishers

Access to resources Recommend Favorite

The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection

By  

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 497-512

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain

By  

Current Pharmaceutical Design, Vol. 21, Iss. 34, 2015-10 ,pp. : 5029-5033

Bentham Science Publishers

Access to resources Recommend Favorite